Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TPTE2 antisense RNA 1 (TPTE2-AS1)
- Target
- TPTE2-AS1
- Molecular classification
- long non-coding RNA, lncRNA, Other
01
Overview
TPTE2 antisense RNA 1 (TPTE2-AS1), also known as LINC00350, is a human long non-coding RNA (lncRNA) transcript located on the opposite DNA strand (antisense) of the TPTE2 protein-coding gene. It does not encode a protein and is classified as a long intergenic non-protein coding RNA. As of the latest available data, there is no established biological function or disease association for TPTE2-AS1; neither is it described as a therapeutic target, and no approved or experimental drugs acting on this RNA are reported. The gene’s expression, potential regulatory roles, and clinical relevance remain uncharacterized in major genetic and biomedical databases.
- Other names
- LINC00350long intergenic non-protein coding RNA 350
02
Biological functions
UnknownNo specific roles or molecular functions are described in main databases or the literature as of the current update
03
Disease associations
OtherNo direct evidence connecting it to major disease categories (e.g. cancer, inflammation) has been reported in main sources as of the current update
Beyond the preview
Go deeper on TPTE2 antisense RNA 1 (TPTE2-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TPTE2 antisense RNA 1 (TPTE2-AS1).